Inflamed Tissue‐Targeting Polyphenol‐Condensed Antioxidant Nanoparticles with Therapeutic Potential
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202500495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Dohyub Jang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomicrosystem Technology, Korea University, Seoul, 02792, Republic of Korea. Hauptthemen laut MEDLINE: Antioxidants, Nanoparticles, Polyphenols, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Science and Technology, Basic Science Research Program, Basic Science Research Program (Priority Research Institute) through the NRF of Korea funded by the Ministry of Education.
Abstract (Originalsprache)
Inflammation is essential for pathogen eradication and tissue repair; However, chronic inflammation can bring on multi‐organ dysfunction due to an overproduction of reactive oxygen species (ROS). Among various anti‐inflammatory agents, polyphenol‐based nanotherapeutics offer potential advantages, including enhanced stability, targeted delivery, multiple therapeutic functions, and personalized therapy tailored to the severity. Despite these advantages, the development of biocompatible nanomedicines capable of selective accumulation in inflamed tissues and efficient inhibition of ROS‐induced inflammatory signaling pathways remains a considerable challenge. In this study, a novel anti‐inflammatory nanotherapeutic is engineered through the temperature‐dependent condensation of polyphenolic catechin facilitated by hydrothermal reactions. The resulting catechin‐condensed nanotherapeutic (CCN150), synthesized at a relatively low temperature, retains physicochemical and functional properties akin to its precursor, catechin, but with a marked enhancement in water solubility. CCN150 protects cells from oxidative stress by eliminating intracellular ROS and augmenting antioxidant enzymes. In vivo studies reveal that intravenously administered CCN150 predominantly accumulates in inflamed tissues, with minimal distribution to healthy regions. Furthermore, CCN150 effectively reduces systemic inflammation in mouse models by disrupting the cycles of ROS instigated by a pro‐inflammatory oxidative milieu. Exhibiting negligible toxicity, CCN150 holds substantial promise for extensive therapeutic applications in the treatment of various ROS‐mediated inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomicrosystem Technology, Korea University, Seoul, 02792, Republic of Korea.
- Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
- KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
- Biosensor Group, Korea Institute of Science and Technology Europe, Campus E7.1, 66123, Saarbrücken, Germany.
- Harvard Institute of Medicine, Harvard Medical School Brigham and Women's Hospital, Harvard University, Boston, MA, 02115, USA.
- Department of Chemical and Biological Engineering, Korea University, Seoul, 02841, Republic of Korea.
ORCID-Profile: Sehoon Kim
Förderung
- Korea Institute of Science and Technology
- Basic Science Research Program
- Basic Science Research Program (Priority Research Institute) through the NRF of Korea funded by the Ministry of Education
- National Research Foundation of Korea
Zitieren
APA
Jang, D., Choi, H., Lee, J., Chun, Y., Heo, Y. H., Lee, L. P., Ahn, D. J., Shin, I. S., Kim, D. H., Seo, Y. H., & Kim, S. (2025). Inflamed Tissue‐Targeting Polyphenol‐Condensed Antioxidant Nanoparticles with Therapeutic Potential. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500495
Vancouver
Jang D, Choi H, Lee J, Chun Y, Heo YH, Lee LP, et al. Inflamed Tissue‐Targeting Polyphenol‐Condensed Antioxidant Nanoparticles with Therapeutic Potential. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500495
BibTeX
@article{Jang2025,
author = {Jang, Dohyub and Choi, Honghwan and Lee, Juhyang and Chun, Yousun and Heo, Yoon-Ho and Lee, Luke P and Ahn, Dong June and Shin, Ik-Soo and Kim, Dong Ha and Seo, Young Hun and Kim, Sehoon},
title = {Inflamed Tissue‐Targeting Polyphenol‐Condensed Antioxidant Nanoparticles with Therapeutic Potential},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202500495}
}
EUVIMED